Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-05-08 @ 1:37 PM
Study NCT ID:
NCT01822951
Status:
WITHDRAWN
Last Update Posted:
2015-10-26
First Post:
2013-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Sponsor:
Ever Neuro Pharma GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EVE-AT-0412
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None